Dianthus Therapeutics (DNTH) shares outstanding

Shares outstanding · fiscal 2025
38.62M

Dianthus Therapeutics (DNTH) had 38.62M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 15.9% higher than the 33.31M of fiscal 2024. Figures as of 18 Nov 2026, 09:57 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
38.62M
Change on fiscal 2024
+15.9%
Highest on record
38.62Mfiscal 2025
Lowest on record
5.15Mfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Dianthus Therapeutics shares outstanding, in more detail

The market data feed counts 56.31M shares outstanding today.

Across the 4 fiscal years on record (2022–2025), the highest was 38.62M in fiscal 2025 and the lowest 5.15M in fiscal 2023.

History · 4 fiscal years

Shares outstanding by fiscal year

Dianthus Therapeutics shares outstanding, year by year

Dianthus Therapeutics (DNTH) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202538.62M 15.9% up
202433.31M 546.4% up
20235.15M 65.2% down
202214.82M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Dianthus Therapeutics and comparable companies
CompanyShares outstandingFiscal year
LivaNova LIVN54.55M2025
Ionis Pharmaceuticals IONS160.00M2025
Dianthus Therapeutics DNTH38.62M2025
Adaptive Biotechnologies ADPT151.72M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DNTH

Dianthus Therapeutics, figure by figure

Dianthus Therapeutics (DNTH) overview: price, valuation and scorecardAll health care companies by market value

Dianthus Therapeutics shares outstanding: questions and answers

How many shares does Dianthus Therapeutics have?

Dianthus Therapeutics (DNTH) had 38.62M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 15.9% higher than the 33.31M of fiscal 2024. The market data feed counts 56.31M shares outstanding today.

What are the highest and lowest diluted share count figures on record for Dianthus Therapeutics?

Across the 4 fiscal years on record (2022–2025), the highest was 38.62M in fiscal 2025 and the lowest 5.15M in fiscal 2023.

How is Dianthus Therapeutics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Dianthus Therapeutics it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Dianthus Therapeutics (DNTH) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/DNTH/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.